Materias dentro de su búsqueda.
Mostrando 2,381 - 2,400 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.77s Limitar resultados
  1. 2381
    “…BACKGROUND: Viral relapse is a major concern in hepatitis C virus (HCV) antiviral therapy. Currently, there are no satisfactory methods to predict viral relapse, especially in the era of direct acting antivirals in which the virus often quickly becomes undetectable using PCR-based approaches that focus on a small viral region. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy
  2. 2382
    “…BACKGROUND: Previous reports show conflicting results regarding hepatitis B virus (HBV) vaccine efficacy in Hepatitis C virus (HCV)-infected individuals. AIMS: To evaluate HBV-vaccine response and identify possible factors that may contribute to lower vaccine efficacy in patients infected with HCV. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection
  3. 2383
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus
  4. 2384
    “…BACKGROUND: Chronic hepatitis C (CHC) can be eliminated as a public health threat by meeting the WHO targets: 90% of patients diagnosed and 80% treated by 2030. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C prevalence in Denmark in 2016—An updated estimate using multiple national registers
  5. 2385
    “…The World Health Organisation's goal of hepatitis C virus (HCV) elimination by 2030 will require lower drug prices. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparing direct acting antivirals for hepatitis C using observational data – Why and how?
  6. 2386
    “…Introduction: As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
  7. 2387
    “…There is a large unmet need for a prophylactic hepatitis C virus (HCV) vaccine to control the ongoing epidemic with this deadly pathogen. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
  8. 2388
    “…Globally, the World Health Organization (WHO) estimates that 71 million people have chronic hepatitis C virus (HCV) infection. A significant number of these will develop cirrhosis or liver cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
  9. 2389
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C
  10. 2390
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
  11. 2391
    “…Both hepatitis C virus (HCV) infection and retinol-binding protein 4 (RBP4) might contribute to insulin resistance (IR), how RBP4 links to IR in HCV infection remain elusive. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter
  12. 2392
    “…BACKGROUND: Hepatitis C virus (HCV) is a disease with a significant global impact, affecting approximately 2%-2.5% of the world’s population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
  13. 2393
    “…BACKGROUND: As the national opioid epidemic escalates, rates of the Hepatitis C (HCV) infection have similarly risen. Surgeons exposed intraoperatively secondary to sharp instrument or needle-sticks are affected both socioeconomically and physically. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessing State Variation in Plastic Surgeons’ Risk of Hepatitis C Exposure: Revisit in Methodology
  14. 2394
    “…BACKGROUND/AIMS: To eliminate hepatitis C virus (HCV) infection, improving public knowledge of and access to HCV screening and treatment is essential. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea
  15. 2395
    “…Hepatitis C virus (HCV) infection is the main cause of hepatocellular carcinoma (HCC) in the United States (US) and an increasingly common cause of HCC in China. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
  16. 2396
    “…Hepatitis C virus (HCV) infection is very common in maintenance hemodialysis patients, causing high morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C
  17. 2397
    “…All blood samples were tested for hepatitis B and C markers including hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibody (anti-HBc), antibodies against hepatitis C virus (anti-HCV). Those reactive for hepatitis C were further tested for HCV RNA genotyping. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian population
  18. 2398
    “…Direct-acting antivirals (DAA) are highly effective for the treatment of hepatitis C (HCV), although there are limited data on the safety and efficacy of DAA therapy in hepatitis C-positive individuals awaiting liver transplantation for hepatocellular carcinoma (HCC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
  19. 2399
    “…BACKGROUND: The role of hepatitis C virus (HCV) coinfection and HCV-RNA in the development of diabetes mellitus (DM) in HIV-positive persons remains unclear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons
  20. 2400
    “…BACKGROUND: Stigma is an important and understudied barrier to hepatitis C virus (HCV) infection treatment and elimination. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1072. The Impact of Hepatitis C-Related Knowledge on Perceptions of Stigma Among Infected Individuals
Herramientas de búsqueda: RSS